title: [Postpartum perineal pain: effectiveness of local ropivacaine infiltration].
abstract: OBJECTIVE
  To assess efficiency of local ropivacaine infiltration in perineal pain after episiotomy and perineal tear during the first 24 h after vaginal delivery.
  
  
  METHODS
  Case control survey, including 62 consecutive patients with episiotomy and/or perineal tear during two consecutive periods: the ropivacaine group from February 2, 2008 to March 27, 2008 (n=31) and the control group from December 27, 2007 to January 1, 2008 (n=31). In the ropivacaine group, patients received 10 ml of ropivacaine 7,5mg/ml as a local infiltration along the perineal damage. In the control group no injection was done. A numerical pain rating scale (0-10) at four (H4), eight (H8), 12 (H12) and 24 h (H24) was used to evaluate patients post-partum perineal pain. A numerical rating scale was used to evaluate patients satisfaction (0: no satisfied, 5: very satisfied).
  
  
  RESULTS
  Numerical pain rating scale for perineal pain evaluation was significantly lower in the ropivacaine group than in the control group at H4 (1.9+/-0.3 versus 3.6+/-0.5, p=0.006), H8 (3.3+/-0.4 versus 5.2+/-0.4, p=0.003), H12 (2.8+/-0.4 versus 5.2+/-0.4, p=0.0001) and H24 (2.6+/-0.4 versus 4.3+/-0.4, p=0.006). Numerical rating scale for satisfaction evaluation was significantly higher in the ropivacaine group (4.2+/-0.2 versus 3.5+/-0.2, p=0.004).
  
  
  CONCLUSIONS
  Local ropivacaine infiltration in episiotomy and/or perineal tear reduce post-partum perineal pain within the first 24 h.
authors.affiliation: Service de gynécologie obstétrique, hôpital Jean-Verdier, AP-HP, université Paris-XIII, avenue du 14-Juillet, 93120 Bondy, France.
authors.forename: S
authors.initials: S
authors.lastname: Sillou
authors.forename: M
authors.initials: M
authors.lastname: Carbonnel
authors.forename: S
authors.initials: S
authors.lastname: N'Doko
authors.forename: G
authors.initials: G
authors.lastname: Dhonneur
authors.forename: M
authors.initials: M
authors.lastname: Uzan
authors.forename: C
authors.initials: C
authors.lastname: Poncelet
mesh_terms: D000328:Adult; D000577:Amides / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000627:therapeutic use*; D016022:Case-Control Studies; D036861:Delivery, Obstetric; D004841:Episiotomy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007267:Injections; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D017060:Patient Satisfaction; D010502:Perineum / Q000293:injuries*; D011247:Pregnancy; D011446:Prospective Studies; D000077212:Ropivacaine
chemical_list: D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine